or
forgot password

    • cancer clinical trials in anchorage, AK

    • Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Lung Cancer
    PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    Alaska Clinical Research Center
    Anchorage, Alaska 99508
    Prostate Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Providence Cancer Center
    Anchorage, Alaska 99508
    Breast Cancer
    Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Alaska Regional Hospital
    Anchorage, Alaska 99508
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Providence Alaska Medical Center

    Trial Locations
    Providence Alaska Medical Center
    Alaska Regional Hospital
    Alzheimer Disease
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Providence Cancer Center
    Anchorage, Alaska 99508
    Endometrial Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Providence Alaska Medical Center

    Trial Locations
    Providence Alaska Medical Center
    Alaska Regional Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Alaska Regional Hospital
    Anchorage, Alaska 99508
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Anchorage, Alaska 99508
    Non Hodgkin Lymphoma
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Lymphoma
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Breast Cancer, Metastatic Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Alaska Regional Hospital
    Anchorage, Alaska 99508
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Anchorage, Alaska 99508
    Neoplasms, Breast, Breast Cancer
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Providence Cancer Center / Katmai Oncology Group LLC
    Anchorage, Alaska 99508
    Breast Cancer
    Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
    Katmai Oncology Group

    Trial Locations
    Katmai Oncology Group
    Anchorage Oncology Centre
    Inflammatory Breast Cancer, Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    Katmai Oncology Group
    Anchorage, Alaska 99508-4627
    Carcinoma, Non-Small-Cell Lung
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer
    Providence Alaska Medical Center

    Trial Locations
    Providence Alaska Medical Center
    Katmai Oncology Group
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Providence Cancer Center
    Anchorage, Alaska 99508
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostate Cancer